CURX (Curanex Pharmaceuticals Inc Common Stock) Stock Analysis - Financials

Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of May 21, 2026, CURX trades at $0.33 with a market cap of $8.53M and a P/E ratio of -1.91. CURX moved +0.00% today. Year to date, CURX is -9.92%; over the trailing twelve months it is flat. Its 52-week range spans $0.26 to $9.18. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CURX's key financials?

CURX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CURX recently traded at $0.33. Market cap is $8.53M. P/E ratio is -1.91. Revenue is $0.

CURX Key Metrics

Key financial metrics for CURX
MetricValue
Price$0.33
Market Cap$8.53M
P/E Ratio-1.91
EPS$-0.17
Dividend Yield0.00%
52-Week High$9.18
52-Week Low$0.26
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$-4.23M
Gross Margin0.00%

CURX Annual Financials

YearRevenueNet IncomeEPS
2025$0$-4.23M$-0.17

Latest CURX News

CURX Analyst Consensus

CURX analyst coverage data. Average price target: $0.00.

Common questions about CURX

What are CURX's key financials?
CURX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CURX recently traded at $0.33. Market cap is $8.53M. P/E ratio is -1.91. Revenue is $0.
Is CURX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURX. It does not provide personalized investment advice.
CURX

CURX